NL7504387A - Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking. - Google Patents
Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking.Info
- Publication number
- NL7504387A NL7504387A NL7504387A NL7504387A NL7504387A NL 7504387 A NL7504387 A NL 7504387A NL 7504387 A NL7504387 A NL 7504387A NL 7504387 A NL7504387 A NL 7504387A NL 7504387 A NL7504387 A NL 7504387A
- Authority
- NL
- Netherlands
- Prior art keywords
- unsubstituted
- alkyl
- dermatophytic
- procedure
- preparation
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 230000000629 anti-dermatophyte Effects 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 206010017533 Fungal infection Diseases 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000222122 Candida albicans Species 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 abstract 1
- 241000223229 Trichophyton rubrum Species 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000006193 alkinyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 229940095731 candida albicans Drugs 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19742418502 DE2418502C3 (de) | 1974-04-11 | 1974-04-11 | Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19752510130 DE2510130A1 (de) | 1975-03-06 | 1975-03-06 | Imidazolderivate und verfahren zu ihrer herstellung |
DE19752510781 DE2510781A1 (de) | 1975-03-07 | 1975-03-07 | Imidazolderivate und verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7504387A true NL7504387A (nl) | 1975-10-14 |
Family
ID=27185894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7504387A NL7504387A (nl) | 1974-04-11 | 1975-04-11 | Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking. |
Country Status (17)
Country | Link |
---|---|
US (1) | US4006243A (is") |
JP (1) | JPS6018654B2 (is") |
AT (1) | AT341518B (is") |
CA (1) | CA1051908A (is") |
CH (1) | CH612185A5 (is") |
CS (1) | CS194221B2 (is") |
DD (1) | DD121515A5 (is") |
DK (1) | DK139909C (is") |
ES (1) | ES436546A1 (is") |
FR (1) | FR2267101B1 (is") |
GB (1) | GB1510016A (is") |
HU (1) | HU172895B (is") |
IE (1) | IE40911B1 (is") |
IL (1) | IL47061A (is") |
NL (1) | NL7504387A (is") |
SE (1) | SE418498B (is") |
YU (1) | YU89875A (is") |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT328587B (de) * | 1973-08-20 | 1976-03-25 | Vianova Kunstharz Ag | Verfahren zur herstellung von wasserigen uberzugsmitteln |
US4237158A (en) * | 1975-02-05 | 1980-12-02 | Rohm And Haas Company | 1-Substituted aralkyl imidazoles and their use as fungicides |
DE2549798C3 (de) * | 1975-11-06 | 1978-06-29 | Nordmark-Werke Gmbh, 2000 Hamburg | 1,2-Dipheny l-3-(imidazo Wl-1 )propene, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel |
US4118461A (en) * | 1975-12-18 | 1978-10-03 | Rohm And Haas Company | 1-Substituted aralkyl imidazoles |
US4115578A (en) * | 1975-12-18 | 1978-09-19 | Rohm And Haas Company | 1-Substituted aralkyl imidazoles |
DE2732750A1 (de) * | 1977-07-20 | 1979-02-08 | Merck Patent Gmbh | Basische thioaether und verfahren zu ihrer herstellung |
US4431815A (en) * | 1977-08-26 | 1984-02-14 | Burroughs Wellcome Co. | 1-[3-(2,4-Dichlorophenyl)propyl]imidazole and salts thereof |
US4284641A (en) * | 1977-08-26 | 1981-08-18 | Burroughs Wellcome Co. | Pharmaceutically active imidazole derivatives |
US4396771A (en) * | 1977-10-19 | 1983-08-02 | Burroughs Wellcome Co. | Imidazole derivatives and salts thereof |
IT1097314B (it) * | 1978-07-26 | 1985-08-31 | Recordati Chem Pharm | Derivati dell'imidazolo ad attivita' anticonvulsivante |
JPS5951943B2 (ja) * | 1978-08-21 | 1984-12-17 | キツセイ薬品工業株式会社 | 新規なイミダゾ−ル誘導体 |
DE2842759A1 (de) * | 1978-09-30 | 1980-04-10 | Merck Patent Gmbh | Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung |
DK531479A (da) * | 1979-01-19 | 1980-07-20 | Pfizer | Fremgangsmaade til fremstilling af imidazolderivater og salte deraf |
DK157860C (da) * | 1979-06-07 | 1990-07-30 | Shionogi & Co | Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf |
US4218461A (en) * | 1979-08-15 | 1980-08-19 | E. R. Squibb & Sons, Inc. | 2,3-Dihydro-2-[(1H-imidazol-1-yl)-methylene]-1H-inden-1-ones |
GB2069481B (en) * | 1980-02-13 | 1983-07-27 | Farmos Oy | Substituted imidazole derivatives |
CA1156661A (en) * | 1980-02-25 | 1983-11-08 | Hoffmann-La Roche Limited | Phenoxy-aminopropanol derivatives |
JPS57502126A (is") * | 1980-12-05 | 1982-12-02 | ||
IL66242A0 (en) * | 1981-07-23 | 1982-11-30 | Erba Farmitalia | N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them |
JPS58150566A (ja) * | 1982-03-03 | 1983-09-07 | Yoshitomi Pharmaceut Ind Ltd | 新規イミダゾ−ル誘導体 |
ES523609A0 (es) * | 1982-07-05 | 1985-03-01 | Erba Farmitalia | Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos. |
GB2126218B (en) * | 1982-08-14 | 1986-01-22 | Wellcome Found | Imidazoles |
JPS60142965A (ja) * | 1983-09-05 | 1985-07-29 | Yoshitomi Pharmaceut Ind Ltd | イミダゾ−ル誘導体の製造法 |
EP0149976A3 (de) * | 1983-12-30 | 1986-12-10 | Ciba-Geigy Ag | Substituierte Imidazole |
US4755526A (en) * | 1984-06-18 | 1988-07-05 | Eli Lilly And Company | Method of inhibiting aromatase |
US4937250A (en) * | 1988-03-07 | 1990-06-26 | Ciba-Geigy Corporation | Alpha-heterocycle substituted tolunitriles |
US4978672A (en) * | 1986-03-07 | 1990-12-18 | Ciba-Geigy Corporation | Alpha-heterocyclc substituted tolunitriles |
US5459145A (en) * | 1988-01-19 | 1995-10-17 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
FI875724A0 (fi) * | 1986-04-29 | 1987-12-28 | Pfizer | Av kalcium oberoende camp fosfodiesteras-inhibitordepressant. |
US5214064A (en) * | 1987-05-02 | 1993-05-25 | Basf Aktiengesellschaft | Phenoxyphenylmethyl substituted azoles and pesticidal composition thereof |
US5280036A (en) * | 1987-05-02 | 1994-01-18 | Basf Aktiengesellschaft | N-phenoxyphenyloxymethyl substituted azoles and method for controlling pests therewith |
CA1329614C (en) * | 1987-05-02 | 1994-05-17 | Rainer Buerstinghaus | N-substituted azoles |
IL91542A0 (en) * | 1988-10-06 | 1990-04-29 | Erba Carlo Spa | N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them |
ZA923283B (en) * | 1991-05-29 | 1993-01-27 | Akzo Nv | Phenoxyphenyl derivatives |
US5395935A (en) * | 1992-05-08 | 1995-03-07 | Pfizer Inc. | Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents |
AU2352295A (en) * | 1994-04-27 | 1995-11-16 | Nippon Soda Co., Ltd. | Imidazole derivative and process for producing the same |
US5922751A (en) * | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
DE19541146A1 (de) * | 1995-10-25 | 1997-04-30 | Schering Ag | Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren |
US6297239B1 (en) | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US6284755B1 (en) | 1998-12-08 | 2001-09-04 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US6632818B2 (en) | 2000-01-12 | 2003-10-14 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
EP1178038A1 (en) | 2000-08-04 | 2002-02-06 | Aventis Cropscience S.A. | Fungicidal phenylamidine derivatives |
JP4377881B2 (ja) | 2003-08-01 | 2009-12-02 | 日本曹達株式会社 | フェニルアゾール化合物、製造法および抗酸化薬 |
JP5518997B2 (ja) | 2009-04-20 | 2014-06-11 | エフ.ホフマン−ラ ロシュ アーゲー | カテプシン阻害薬としてのプロリン誘導体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1908991B2 (de) * | 1969-02-22 | 1977-05-26 | Bayer Ag, 5090 Leverkusen | Alpha, alpha-disubstituierte n- benzylimidazole und deren salze |
DE2007794A1 (de) * | 1970-02-20 | 1971-09-02 | Farbenfabriken Bayer Aktiengesell schaft, 5090 Leverkusen | Fungizide Mittel |
US3833603A (en) * | 1970-04-09 | 1974-09-03 | Bayer Ag | 1-(alpha,alpha-disubstituted 4-phenoxy-benzyl)imidazoles |
NL7108387A (is") * | 1970-06-22 | 1971-12-24 | Koninklijke Pharma Fab Nv | |
US3927017A (en) * | 1974-06-27 | 1975-12-16 | Janssen Pharmaceutica Nv | 1-({62 -Aryl-{62 -R-ethyl)imidazoles |
-
1975
- 1975-04-08 IE IE780/75A patent/IE40911B1/xx unknown
- 1975-04-09 DD DD185337A patent/DD121515A5/xx unknown
- 1975-04-09 YU YU00898/75A patent/YU89875A/xx unknown
- 1975-04-09 DK DK153075A patent/DK139909C/da not_active IP Right Cessation
- 1975-04-09 AT AT268675A patent/AT341518B/de not_active IP Right Cessation
- 1975-04-09 CS CS752431A patent/CS194221B2/cs unknown
- 1975-04-10 IL IL7547061A patent/IL47061A/xx unknown
- 1975-04-10 SE SE7504123A patent/SE418498B/xx unknown
- 1975-04-10 HU HU75SC00000516A patent/HU172895B/hu unknown
- 1975-04-10 CH CH457575A patent/CH612185A5/xx not_active IP Right Cessation
- 1975-04-11 FR FR7511415A patent/FR2267101B1/fr not_active Expired
- 1975-04-11 US US05/567,361 patent/US4006243A/en not_active Expired - Lifetime
- 1975-04-11 CA CA224,402A patent/CA1051908A/en not_active Expired
- 1975-04-11 GB GB15012/75A patent/GB1510016A/en not_active Expired
- 1975-04-11 NL NL7504387A patent/NL7504387A/xx not_active Application Discontinuation
- 1975-04-11 ES ES75436546A patent/ES436546A1/es not_active Expired
- 1975-04-11 JP JP50044147A patent/JPS6018654B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
SE7504123L (sv) | 1975-12-19 |
IL47061A0 (en) | 1975-06-25 |
DD121515A5 (is") | 1976-08-05 |
YU89875A (en) | 1982-05-31 |
DK139909B (da) | 1979-05-14 |
DK139909C (da) | 1979-10-08 |
JPS50148357A (is") | 1975-11-27 |
HU172895B (hu) | 1978-12-28 |
SE418498B (sv) | 1981-06-09 |
FR2267101B1 (is") | 1980-01-25 |
CA1051908A (en) | 1979-04-03 |
US4006243A (en) | 1977-02-01 |
IE40911L (en) | 1975-10-11 |
JPS6018654B2 (ja) | 1985-05-11 |
CS194221B2 (en) | 1979-11-30 |
ATA268675A (de) | 1977-06-15 |
FR2267101A1 (is") | 1975-11-07 |
ES436546A1 (es) | 1977-01-16 |
CH612185A5 (is") | 1979-07-13 |
IE40911B1 (en) | 1979-09-12 |
GB1510016A (en) | 1978-05-10 |
AT341518B (de) | 1978-02-10 |
IL47061A (en) | 1978-08-31 |
AU8002575A (en) | 1976-10-14 |
DK153075A (is") | 1975-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL7504387A (nl) | Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking. | |
NL168509C (nl) | Werkwijze ter bereiding van een therapeutisch preparaat, alsmede werkwijze ter bereiding van daarvoor geschikte verbindingen. | |
BR9908764A (pt) | Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica | |
KR910006200A (ko) | 퀴논 유도체 및 약리학적 이용 | |
DK568187A (da) | Transdermal flux-foroegende praeparat | |
KR920700201A (ko) | 신규 1α-히드록시비타민D 2 에피머 및 유도체 | |
KR920004385A (ko) | 신규 삼환화합물 또는 그의 염, 이의 제조방법 및 이를 함유하는 항균제 | |
KR900009606A (ko) | 불소-함유 2-니트로 이미다졸 유도체 및 그를 함유하는 방사선 증감제 | |
KR880012532A (ko) | 신규 비시클릭화합물, 그의 제조방법 및 이 화합물로 되는 제약조성물 | |
KR890000482A (ko) | (8β)-1-알킬-6-(치환된) 에르 골린의 시클로알킬아미드 | |
DE3576075D1 (de) | 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
ATE182468T1 (de) | Bistriazene als chemotherapeutische mittel | |
KR910000647A (ko) | 나프틸아미노-및 나프틸옥시- 피리딘아민 및 관련된 화합물, 이의 제조방법 및 이의 피부소염제로서의 용도 | |
GB1185096A (en) | Improvements in or relating to Antibiotic Derivatives and the manufacture thereof | |
GB1289240A (is") | ||
KR890003692A (ko) | 1.2.5.6- 테트라히드로피리딘-3-카르복스알데히드의 옥심유도체, 이들의 제조방법, 약제로서의 이들의 용도 및 이들을 함유하는 조성물 | |
DE60031699D1 (de) | Hydroxyacetamidobenzolsulfonamidderivate | |
KR880007490A (ko) | 치환된 아미노프로피온아미드, 이의 제조방법, 이를 함유하는 약제, 이의 용도 및 이의 제조시에 생성된 중간체 | |
KR830001900A (ko) | 페닐모르판과 그의 중간물질및 제조방법 | |
KR870004038A (ko) | 제초제 화합물의 제조방법 | |
KR900701273A (ko) | 진토성 에르골린 유도체 | |
ES397453A1 (es) | Procedimiento para la preparacion de derivados de imidazo- lina. | |
KR880009032A (ko) | 이미다조-및 트리아졸로티아디아진, 이의 제조방법, 이를 함유하는 약체 및 이의 용도, 및 이의 중간체 | |
KR910000648A (ko) | 페녹시피리딘아민 및 이의 유도체, 제조방법 및 약제로서의 용도 | |
KR920002594A (ko) | 5-이소티아졸아민 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
BV | The patent application has lapsed |